288 related articles for article (PubMed ID: 25736227)
21. Primary B Lymphocytes Infected with Kaposi's Sarcoma-Associated Herpesvirus Can Be Expanded In Vitro and Are Recognized by LANA-Specific CD4+ T Cells.
Nicol SM; Sabbah S; Brulois KF; Jung JU; Bell AI; Hislop AD
J Virol; 2016 Apr; 90(8):3849-3859. PubMed ID: 26819313
[TBL] [Abstract][Full Text] [Related]
22. 3D culture conditions support Kaposi's sarcoma herpesvirus (KSHV) maintenance and viral spread in endothelial cells.
Dubich T; Dittrich A; Bousset K; Geffers R; Büsche G; Köster M; Hauser H; Schulz TF; Wirth D
J Mol Med (Berl); 2021 Mar; 99(3):425-438. PubMed ID: 33484281
[TBL] [Abstract][Full Text] [Related]
23. Minimal reactivation of Kaposi's sarcoma-associated herpesvirus by corticosteroids in latently infected B cell lines.
Zoeteweij JP; Rinderknecht AS; Davis DA; Yarchoan R; Blauvelt A
J Med Virol; 2002 Mar; 66(3):378-83. PubMed ID: 11793390
[TBL] [Abstract][Full Text] [Related]
24. Activation of the B cell antigen receptor triggers reactivation of latent Kaposi's sarcoma-associated herpesvirus in B cells.
Kati S; Tsao EH; Günther T; Weidner-Glunde M; Rothämel T; Grundhoff A; Kellam P; Schulz TF
J Virol; 2013 Jul; 87(14):8004-16. PubMed ID: 23678173
[TBL] [Abstract][Full Text] [Related]
25. HIV-1 infection of primary effusion lymphoma cell line triggers Kaposi's sarcoma-associated herpesvirus (KSHV) reactivation.
Merat R; Amara A; Lebbe C; de The H; Morel P; Saib A
Int J Cancer; 2002 Feb; 97(6):791-5. PubMed ID: 11857356
[TBL] [Abstract][Full Text] [Related]
26. Use of the red fluorescent protein as a marker of Kaposi's sarcoma-associated herpesvirus lytic gene expression.
Vieira J; O'Hearn PM
Virology; 2004 Aug; 325(2):225-40. PubMed ID: 15246263
[TBL] [Abstract][Full Text] [Related]
27. Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 infection in reactive lymphoid tissues: a model for KSHV/HHV-8-related lymphomas?
Lazzi S; Bellan C; Amato T; Palummo N; Cardone C; D'Amuri A; De Luca F; Beyanga M; Facchetti F; Tosi P; Leoncini L
Hum Pathol; 2006 Jan; 37(1):23-31. PubMed ID: 16360412
[TBL] [Abstract][Full Text] [Related]
28. OX40 and 4-1BB downregulate Kaposi’s sarcoma-associated herpesvirus replication in lymphatic endothelial cells, but 4-1BB and not OX40 inhibits viral replication in B-cells.
Cho M; Myoung J
J Gen Virol; 2015 Dec; 96(12):3635-3645. PubMed ID: 26467721
[TBL] [Abstract][Full Text] [Related]
29. Kaposi's Sarcoma-Associated Herpesvirus-Encoded circRNAs Are Expressed in Infected Tumor Tissues and Are Incorporated into Virions.
Abere B; Li J; Zhou H; Toptan T; Moore PS; Chang Y
mBio; 2020 Jan; 11(1):. PubMed ID: 31911496
[TBL] [Abstract][Full Text] [Related]
30. Lytic induction of Kaposi's sarcoma-associated herpesvirus in primary effusion lymphoma cells with natural products identified by a cell-based fluorescence moderate-throughput screening.
Cho HJ; Yu F; Sun R; Lee D; Song MJ
Arch Virol; 2008; 153(8):1517-25. PubMed ID: 18607675
[TBL] [Abstract][Full Text] [Related]
31. Kaposi's Sarcoma-Associated Herpesvirus: Epidemiology and Molecular Biology.
Li S; Bai L; Dong J; Sun R; Lan K
Adv Exp Med Biol; 2017; 1018():91-127. PubMed ID: 29052134
[TBL] [Abstract][Full Text] [Related]
32. Human herpesvirus 6 activates lytic cycle replication of Kaposi's sarcoma-associated herpesvirus.
Lu C; Zeng Y; Huang Z; Huang L; Qian C; Tang G; Qin D
Am J Pathol; 2005 Jan; 166(1):173-83. PubMed ID: 15632010
[TBL] [Abstract][Full Text] [Related]
33. Kaposi's sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53.
Rivas C; Thlick AE; Parravicini C; Moore PS; Chang Y
J Virol; 2001 Jan; 75(1):429-38. PubMed ID: 11119611
[TBL] [Abstract][Full Text] [Related]
34. Pathology of Kaposi's Sarcoma-Associated Herpesvirus Infection.
Fukumoto H; Kanno T; Hasegawa H; Katano H
Front Microbiol; 2011; 2():175. PubMed ID: 21904536
[TBL] [Abstract][Full Text] [Related]
35. Lytic replication-defective Kaposi's sarcoma-associated herpesvirus: potential role in infection and malignant transformation.
Deng JH; Zhang YJ; Wang XP; Gao SJ
J Virol; 2004 Oct; 78(20):11108-20. PubMed ID: 15452231
[TBL] [Abstract][Full Text] [Related]
36. Kaposi's sarcoma-associated herpesvirus sequences in benign lymphoid proliferations not associated with human immunodeficiency virus.
Chadburn A; Cesarman E; Nador RG; Liu YF; Knowles DM
Cancer; 1997 Aug; 80(4):788-97. PubMed ID: 9264363
[TBL] [Abstract][Full Text] [Related]
37. Reactivation of Kaposi's sarcoma-associated herpesvirus by natural products from Kaposi's sarcoma endemic regions.
Whitby D; Marshall VA; Bagni RK; Miley WJ; McCloud TG; Hines-Boykin R; Goedert JJ; Conde BA; Nagashima K; Mikovits J; Dittmer DP; Newman DJ
Int J Cancer; 2007 Jan; 120(2):321-8. PubMed ID: 17066452
[TBL] [Abstract][Full Text] [Related]
38. Distinct patterns of viral antigen expression in Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus coinfected body-cavity-based lymphoma cell lines: potential switches in latent gene expression due to coinfection.
Callahan J; Pai S; Cotter M; Robertson ES
Virology; 1999 Sep; 262(1):18-30. PubMed ID: 10489337
[TBL] [Abstract][Full Text] [Related]
39. Activation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) lytic replication by human cytomegalovirus.
Vieira J; O'Hearn P; Kimball L; Chandran B; Corey L
J Virol; 2001 Feb; 75(3):1378-86. PubMed ID: 11152511
[TBL] [Abstract][Full Text] [Related]
40. Recent advances in understanding Kaposi's sarcoma-associated herpesvirus.
Dissinger NJ; Damania B
F1000Res; 2016; 5():. PubMed ID: 27158465
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]